摘要
立他斯特是首个对干眼症的症状和体征均有作用的消炎眼部滴剂。对立他斯特的专利申请状况和专利技术进行分析,旨在为国内研发机构和制药企业提供有益的研究方向和在专利布局方面的建议。
Lifitegrast is the first anti-inflammatory eye drop to treat both symptoms and signs of dry eye.In this paper,analysis of the patent application status and patented technology of Lifitegrast.It aims to provide beneficial research directions and suggestions in terms of patent distribution to domestic research institutions and pharmaceutical companies.
作者
南艳
范鑫鑫
甘雨
Nan Yan;Fan Xinxin;Gan Yu(Patent Examination Cooperation(Beijing)Center of the Patent Office,Beijing 100160,China)
出处
《山东化工》
CAS
2022年第24期176-178,共3页
Shandong Chemical Industry